$SPHS..Solid post highlighting the benefits & risks. I don't prefer to hold thru a double-blinded study. Definitely prefer open-label where the company can follow patients. If it hits it will move the stock. Definitely a high risk/reward!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.